선행요법 없이 초기치료로서 수술을 시행했던 예측되지 않은 N2 비소세포폐암의 치료 성적

심만식,김진국,윤유상,장성욱,김홍관,최용수,김관민,심영목 대한흉부외과학회 2010 Journal of Chest Surgery (J Chest Surg) Vol.43 No.1

Background: Preoperative chemotherapy has been adopted in our hospital as a standard treatment for non-small cell lung cancer patients with N2 disease. However, there have been cases of pathologic N2 disease that have been detected after curative-intent surgical resection. We retrospectively studied the outcomes of initial surgical treatment without neoadjuvant therapy in patients with unexpected N2 non-small cell lung cancer. Material and Method: Between January 1995 and June 2007, 225 patients were diagnosed with pathologic N2 disease after they underwent initial pulmonary resection without neoadjuvant therapy. Among them, 170 patients were preoperatively diagnosed with lymph node stage N0 or N1. We retrospectively reviewed their medical record and analyzed the outcomes. Result: The overall 5-year survival rate was 35.4%. The prognostic factors that were significantly associated with survival were no adjuvant therapy, histologic cell types other than adenocarcinoma or squamous cell carcinoma, a pathologic T stage more than T1, old age (≥70 years) and no mediastinoscopic biopsy. During the follow-up, 79 patients (46.5%) experienced tumor recurrence, including loco-regional recurrence in 20 patients (25.3%) and distant metastasis in 56 (70.9%). The 5-year recurrence-free survival rate was 33.7%. Conclusion: Based on our findings, the survival was good for patients with unexpected N2 non-small cell lung cancer and who underwent initial pulmonary resection without neoadjuvant therapy. A prospective comparative analysis is needed to obtain more conclusive and persuasive results. 배경: 수술 전 항암요법은 원발 종양과 같은 쪽 종격동 또는 기관용골하 림프절전이가 있는 비소세포폐암(N2 질환)에 대한 치료로서 본원의 치료방침으로 사용 중이나, 병기결정을 위한 검사들의 위음성(false-negative)으로 인해 선행요법 없이 수술한 뒤 병리학적으로 N2 질환으로 진단되는 경우가 있다. 이에 초기 치료로서 수술을 시행했던 예측되지 않은 N2 비소세포폐암 치료의 성적을 후향적으로 분석하였다. 대상 및 방법: 1995년 1월부터 2007년 6월까지 비소세포폐암으로 진단받고 초기 치료로서 폐절제술을 시행한 뒤 병리학적 N2로 확인된 225명의 환자들 중 술 전 림프절 병기가 N0 또는 N1이었던 170명의 환자들 연구 대상하여 의무기록을 후향적으로 분석하여 생존율과 무재발 생존율 및 재발양상을 분석하였으며 생존율에 관계된 예후인자에 대하여 조사하였다. 결과: 5년 전체 생존율(overall survival rate)은 35.4%였고, 중앙 생존 기간(median survival time)은 31개월이었다. 생존율에 영향을 미치는 인자로서 술 후 보조요법을 받지 않은 경우, 조직학적 유형이 선암이나 편평상피세포암이 아닌 경우, 병리학적 T 병기가 T2 이상인 경우, 70세 이상의 고령, 술 전 종격동내시경을 시행하지 않은 경우에 예후가 더 불량한 것으로 나타났다. 경과 관찰 중 79명(46.5%)에서 재발이 확인되었고 이중 20명(25.3%)은 국소재발이었고 56명(70.9%)은 원격전이로 재발하였다. 5년 무재발 생존율은 33.7%였다. 결론: 본 연구에서는 초기 치료로서 수술을 시행했던 예측되지 않은 N2 비소세포폐암 환자들의 생존율에 있어 비교적 좋은 성적을 보이고 있다. 하지만 보다 설득력 있는 결과를 위해서는 전향적 비교분석 연구가 필요하다.

일차 심장 이식 후 발생한 Cardiac Allograft Vasculopathy의 치료로서의 심장 재이식 −1예 보고−

심만식,성기익,김욱성,이영탁,전은석,박표원 대한흉부외과학회 2010 Journal of Chest Surgery (J Chest Surg) Vol.43 No.1

Cardiac allograft vasculopathy (CAV) is a major factor that limits the long-term survival after cardiac transplantation. Because the main feature of CAV is a diffuse stenosis that predominantly develops in the distal arteries, reperfusion therapy has shown poor outcomes. The results of cardiac retransplantation for CAV are better than that for acute resection and the survival is identical to that of patients who undergo primary transplantation. We describe a case of performing cardiac retransplantation in a 28 year-old male patient with refractory CAV and who underwent primary transplantation due to dilated cardiomyopathy 8 years previously. Cardiac allograft vasculopathy (CAV)는 심장 이식 환자의 장기 생존율을 결정하는 중요한 합병증으로서 원위부 혈관의 미만성 병변을 가지는 것이 특징으로 재관류요법을 적용하기 어렵고 성적이 좋지 않다. CAV에 대한 치료로서 심장 재이식은 급성거부반응으로 재이식을 하는 경우보다 예후가 좋고 일차 심장이식 후의 결과와 비슷한 정도로 보고되고 있다. 이에 저자들은 28세 남자 환자로 8년 전에 확장성 심근증으로 일차 심장이식을 받은 뒤 만성 거부 반응으로 CAV가 발생하여 경피적 관상동맥 확장술을 시행하였으나 재협착과 심부전의 반복으로 더 이상의 재관류요법이 어려운 환자에게 심장 재이식을 하여 치료하였기에 보고하는 바이다.

우심실 종괴로 나타난 고환 태생암의 심장 전이

심만식,김욱성,성기익,이영탁,박표원,임호영 대한흉부외과학회 2010 Journal of Chest Surgery (J Chest Surg) Vol.43 No.1

Metastases to the heart are rarely diagnosed before the patient dies. A 26-year-old man was admitted with multiple metastasis of a testicular embryonal carcinoma and he was found to have intracardiac metastasis. Echocardiography showed that he had a mass rising from the interventricular septum and it was floating through the right ventricular outflow tract. The histology of the mass we removed from the right ventricle was consistent with testicular embryonal carcinoma. The patient made a smooth recovery after surgical intervention and chemotherapy. We believe this is the first reported case of testicular embryonal carcinoma that metastasized to the heart and that was successfully removed via surgery in Korea. 심장 전이는 환자가 사망하기 전에 진단되는 경우가 드물다. 저자들은 고환 융모암의 다발성전이를 보였던 26세 남자에서 심장 전이를 진단하였고 심장초음파에서 심실중격에서 기원하여 우심실유출로에 유동하는 종괴를 확인할 수 있었다. 우심실로부터 제거한 종괴의 조직학적 소견은 고환 융모암에 합당한 소견을 보였고 환자는 수술적 치료 및 항암화학요법 후에 안정된 회복을 보였다. 국내에는 고환 융모암의 심장 전이를 수술적으로 제거함으로써 성공적인 치료 효과를 보였던 증례 보고가 없어 보고하고자 한다.

[찬성] 새로운 대중교통수단, 경전철

심만식 열린전북 2000 열린전북 Vol.8 No.-

Clinical Outcomes after Anatomic Repair Including Hemi-Mustard Operation in Patients with Congenitally Corrected Transposition of the Great Arteries

심만식,전태국,양지혁,박표원,조양현,강석,허준,송진영 대한심장학회 2017 Korean Circulation Journal Vol.47 No.2

Background and Objectives: The aims of this study were to determine the early and late outcomes of anatomic repair of congenitally corrected transposition of the great arteries (ccTGA) and to evaluate effectiveness of the hemi-Mustard procedure. Subjects and Methods: We conducted a retrospective, single-center study of patients who underwent anatomic repair for ccTGA between July 1996 and December 2013. Sixteen patients were included in the study. The median age at the time of the operation was 3.5 years (range: 0.5-29.7), and the median body weight was 13.3 kg (range: 5.8-54). The median follow-up duration was 7.7 years (range: 0.2-17.4). Results: Atrial switch was achieved using the Mustard procedure in 12 patients (hemi-Mustard procedure in 11) or the Senning procedure in four patients. The ventriculoarterial procedure was performed using the Rastelli procedure in 11 patients and arterial switch in five patients. Six patients underwent tricuspid valvuloplasty. The survival rate was 93.8±6.1%. The rate of freedom from reoperation at 5 years was 92.3±7.4% in the Rastelli group. All patients except one were New York Heart Association class I. All patients except one had mild tricuspid regurgitation. Conclusion: Anatomic repair can be performed with a low risk of in-hospital mortality. The hemi-Mustard strategy for selected patients is one solution for reducing early mortality and morbidity, and long-term complications such as venous pathway stenosis or sinus node dysfunction.

Right Aortic Arch with a Retroesophageal Left Subclavian Artery and an Anomalous Origin of the Pulmonary Artery from the Aorta

전창석,심만식,양지혁,전태국 대한흉부외과학회 2017 Journal of Chest Surgery (J Chest Surg) Vol.50 No.1

We report the case of a newborn with a rare anatomic variation: a right aortic arch with a retroesophageal left subclavian artery and an anomalous origin of the pulmonary artery from the aorta. This variation was diagnosed using echocardiography and computed tomography, and we treated the condition surgically.

The Absence of Atrial Contraction as a Predictor of Permanent Pacemaker Implantation after Maze Procedure with Cryoablation

전창석,심만식,박승정,정동섭,박경민,온영근,김준수,박표원 대한흉부외과학회 2017 Journal of Chest Surgery (J Chest Surg) Vol.50 No.3

Background: The absence of atrial contraction (AC) after the maze procedure has been reported to cause subsequent annular dilatation and to increase the risk of embolic stroke. We hypothesized that the lack of AC could increase the risk of permanent pacemaker (PPM) implantation in patients undergoing the maze procedure. Methods: In 376 consecutive patients who had undergone a cryo-maze procedure and combined valve operation, recovery of AC was assessed at baseline and at immediate (≤2 weeks), early (≤1 year, 4.6±3.8 months), and late (>1 year, 3.5±1.1 years) postoperative stages. Results: With a median follow-up of 53 months, 10 patients underwent PPM implantation. Seven PPM implants were for sinus node dysfunction (pauses of 9.6±2.4 seconds), one was for marked sinus bradycardia, and two were for advanced/complete atrioventricular block. The median (interquartile range) time to PPM implantation was 13.8 (0.5–68.2) months. Our time-varying covariate Cox models showed that the absence of AC was a risk factor for PPM implantation (hazard ratio, 11.92; 95% confidence interval, 2.52 to 56.45; p=0.002). Conclusion: The absence of AC may be associated with a subsequent risk of PPM implantation.

The Right Ventricular Myxoma Which Attached to the Tricuspid Valve: Sliding Tricuspid Valvuloplasty

조성호,김욱성,심만식 대한흉부외과학회 2015 Journal of Chest Surgery (J Chest Surg) Vol.48 No.3

We report a rare case of an extremely large right ventricular myxoma involving the ventricular side of the tricuspid valve. The tumor was excised along with the entire posterior leaflet and part of the anterior leaflet. The tricuspid valve was repaired by sliding valvuloplasty combined with ring annuloplasty.

Mass lesions that almost fill the ascending aorta: When to operate?

김지연,김소윤,심만식,박재형 대한내과학회 2021 대한내과학회 추계학술대회 Vol.2021 No.1

Pulmonary Root Translocation with the Lecompte Maneuver: For Transposition of the Great Arteries with Ventricular Septal Defect and Pulmonary Stenosis

윤동욱,전태국,김태호,심만식,장재석 대한흉부외과학회 2015 Journal of Chest Surgery (J Chest Surg) Vol.48 No.5

A five-month-old boy who had undergone previously transcatheter balloon atrioseptostomy at 3 days of age for complete transposition of the great arteries with ventricular septal defect and pulmonary stenosis underwent pulmonary root translocation with the Lecompte maneuver. This operation has the advantages of maintaining pulmonary valve function, preserving the capacity for growth, and avoiding problems inherent to the right ventricular to pulmonary artery conduit. This patient progressed well for 9 months postoperatively and we report this case of pulmonary root translocation with the Lecompte maneuver.